Sakar Healthcare Stock Price Analysis and Quick Research Report. Is Sakar Healthcare an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Sakar Healthcare. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Sakar Healthcare has a PE ratio of 39.4091494504331 which is high and comparatively overvalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Sakar Healthcare has ROA of 4.3532% which is a bad sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Sakar Healthcare has a Current ratio of 1.4054.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Sakar Healthcare has a ROE of 6.4787%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Sakar Healthcare has a Debt to Equity ratio of 0.3056 which means that the company has low proportion of debt in its capital.

• Sales growth: Sakar Healthcare has reported revenue growth of 15.8022% which is fair in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Sakar Healthcare for the current financial year is 28.1785536704457%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Sakar Healthcare is Rs 0 and the yield is 0%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Sakar Healthcare is Rs 11.3362. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Sakar Healthcare in Ticker for free. Also, one can get the intrinsic value of Sakar Healthcare by using Valuation Calculators, which are available with a Finology ONE subscription. 

Sakar Healthcare FAQs

Q1. What is Sakar Healthcare share price today?
Ans: The current share price of Sakar Healthcare is Rs 446.75.

Q2. What is the market capitalisation of Sakar Healthcare?
Ans: Sakar Healthcare has a market capitalisation of Rs 994.01472925 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Sakar Healthcare?
Ans: The PE ratio of Sakar Healthcare is 39.4091494504331 and the P/B ratio of Sakar Healthcare is 3.16981105300875, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Sakar Healthcare share?
Ans: The 52-week high share price of Sakar Healthcare is Rs 504.7, and the 52-week low share price of Sakar Healthcare is Rs 210.1.

Q5. Does Sakar Healthcare pay dividends?
Ans: Currently, Sakar Healthcare does not pay dividends. Dividend yield of Sakar Healthcare is around 0%.

Q6. What are the face value and book value of Sakar Healthcare shares?
Ans: The face value of Sakar Healthcare shares is Rs 10, while the book value per share of Sakar Healthcare is around Rs 140.939. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Sakar Healthcare?
Ans: Sakar Healthcare has a total debt of Rs 86.3747 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Sakar Healthcare?
Ans: The ROE of Sakar Healthcare is 6.4787% and ROCE of Sakar Healthcare is 8.5245%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Sakar Healthcare a good buy for the long term?
Ans: The Sakar Healthcare long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Sakar Healthcare undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Sakar Healthcare appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Sakar Healthcare’s financials?
Ans: You can review Sakar Healthcare’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.